116 related articles for article (PubMed ID: 12086486)
1. Novel, non-acylguanidine-type Na(+)/H(+) exchanger inhibitors: synthesis and pharmacology of 5-tetrahydroquinolinylidene aminoguanidine derivatives.
Fukumoto S; Imamiya E; Kusumoto K; Fujiwara S; Watanabe T; Shiraishi M
J Med Chem; 2002 Jul; 45(14):3009-21. PubMed ID: 12086486
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.
Kusumoto K; Igata H; Abe A; Ikeda S; Tsuboi A; Imamiya E; Fukumoto S; Shiraishi M; Watanabe T
Br J Pharmacol; 2002 Apr; 135(8):1995-2003. PubMed ID: 11959803
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective inhibition of the human Na+/H+ exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559.
Kawamoto T; Kimura H; Kusumoto K; Fukumoto S; Shiraishi M; Watanabe T; Sawada H
Eur J Pharmacol; 2001 May; 420(1):1-8. PubMed ID: 11412833
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Na(+)/H(+) exchanger-1 inhibitory activity of substituted (quinolinecarbonyl)guanidine derivatives.
Mao D; Xu Y; Hu X; Zhang G; Dong J; Gong G
Chem Biodivers; 2009 Oct; 6(10):1727-36. PubMed ID: 19842138
[TBL] [Abstract][Full Text] [Related]
5. (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1.
Lee S; Yi KY; Hwang SK; Lee BH; Yoo SE; Lee K
J Med Chem; 2005 Apr; 48(8):2882-91. PubMed ID: 15828827
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na(+)/H(+) exchanger.
Laeckmann D; Rogister F; Dejardin JV; Prosperi-Meys C; Géczy J; Delarge J; Masereel B
Bioorg Med Chem; 2002 Jun; 10(6):1793-804. PubMed ID: 11937337
[TBL] [Abstract][Full Text] [Related]
7. (2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors.
Baumgarth M; Beier N; Gericke R
J Med Chem; 1997 Jun; 40(13):2017-34. PubMed ID: 9207943
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and quantitative structure-activity relationship study of N-(3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-7-carbonyl)guanidine derivatives as potent Na/H exchange inhibitors.
Yamamoto T; Hori M; Watanabe I; Tsutsui H; Harada K; Ikeda S; Maruo J; Morita T; Ohtaka H
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1975-83. PubMed ID: 9433767
[TBL] [Abstract][Full Text] [Related]
9. Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1.
Ahmad S; Doweyko LM; Dugar S; Grazier N; Ngu K; Wu SC; Yost KJ; Chen BC; Gougoutas JZ; DiMarco JD; Lan SJ; Gavin BJ; Chen AY; Dorso CR; Serafino R; Kirby M; Atwal KS
J Med Chem; 2001 Sep; 44(20):3302-10. PubMed ID: 11563929
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and quantitative structure-activity relationships of N-(3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-6-carbonyl)guanidines as Na/H exchange inhibitors.
Yamamoto T; Hori M; Watanabe I; Tsutsui H; Harada K; Ikeda S; Maruo J; Morita T; Ohtaka H
Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1716-23. PubMed ID: 9845955
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.
Xu WT; Jin N; Xu J; Xu YG; Wang QJ; You QD
Bioorg Med Chem Lett; 2009 Jun; 19(12):3283-7. PubMed ID: 19433354
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.
Zhang R; Dong J; Xu YG; Hua WY; Wen N; You QD
Eur J Med Chem; 2009 Sep; 44(9):3771-6. PubMed ID: 19482383
[TBL] [Abstract][Full Text] [Related]
13. Infarct size limitation by a new Na(+)-H+ exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C.
Miura T; Ogawa T; Suzuki K; Goto M; Shimamoto K
J Am Coll Cardiol; 1997 Mar; 29(3):693-701. PubMed ID: 9060913
[TBL] [Abstract][Full Text] [Related]
14. 4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitors.
Lee S; Lee H; Yi KY; Lee BH; Yoo SE; Lee K; Cho NS
Bioorg Med Chem Lett; 2005 Jun; 15(12):2998-3001. PubMed ID: 15914000
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic characteristics and cardioprotective effects of new NHE1 inhibitors.
Kim J; Jung YS; Han W; Kim MY; Namkung W; Lee BH; Yi KY; Yoo SE; Lee MG; Kim KH
Eur J Pharmacol; 2007 Jul; 567(1-2):131-8. PubMed ID: 17482160
[TBL] [Abstract][Full Text] [Related]
16. Impact of extracellular buffer composition on cardioprotective efficacy of Na+/H+ exchanger inhibitors.
Shimada Y; Hearse DJ; Avkiran M
Am J Physiol; 1996 Feb; 270(2 Pt 2):H692-700. PubMed ID: 8779847
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury.
Aihara K; Hisa H; Sato T; Yoneyama F; Sasamori J; Yamaguchi F; Yoneyama S; Mizuno Y; Takahashi A; Nagai A; Kimura T; Kogi K; Satoh S
Eur J Pharmacol; 2000 Sep; 404(1-2):221-9. PubMed ID: 10980282
[TBL] [Abstract][Full Text] [Related]
18. Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart.
Lee BH; Seo HW; Yi KY; Lee S; Lee S; Yoo SE
Eur J Pharmacol; 2005 Mar; 511(2-3):175-82. PubMed ID: 15792786
[TBL] [Abstract][Full Text] [Related]
19. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
Lee BH; Yi KY; Lee S; Lee S; Yoo SE
Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for potential Na/H exchange inhibitors obtained from quantitative structure-activity relationships of monocyclic and bicyclic aroylguanidines.
Yamamoto T; Hori M; Watanabe I; Tsutsui H; Harada K; Ikeda S; Ohtaka H
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1282-6. PubMed ID: 9377779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
